Healthcare
July 2025
Johns Hopkins researchers have successfully demonstrated SRT-H, an advanced AI-powered surgical robot, which performed the most complex phase of a gallbladder removal on pig cadaver models designed to simulate real human anatomy. Trained by watching expert surgeons and responding to spoken commands, the robot adapted to anatomical differences and unexpected changes in real time. It completed all 17 surgical steps with 100% accuracy, matching the precision of expert surgeons. This is a tested prototype, not yet used on live human patients, but marks a major step toward real-world autonomous surgical systems.
In July 2025, AIIMS Nagpur successfully tested and demonstrated the BHISHM Cube, a modular mobile medical unit designed for rapid disaster response. Comprising 72 compact aluminum cubes, the system can be air-dropped or transported to remote areas and assembled into a fully functional field hospital within minutes. During the live demonstration, the cube system was shown to support 10–15 surgeries per day and treat up to 200 patients, complete with surgical tools, IV supplies, and multilingual tablet support. This tested prototype is now positioned as a breakthrough in emergency healthcare infrastructure, particularly for disaster-hit or inaccessible regions.
Oct 2024
October 17, 2024 A new vaccine offers hope for treating and preventing the infectious and difficult-to-treat infection with Clostridium difficile, also known as C. difficile or C. diff. In animal models, this is the first C. difficile mRNA-LNP vaccine that protects against C . According to the researchers, it improves primary and new infections by stimulating a strong immune response, eliminating C. diff bacteria from the gut, and even overcoming the weakness of the host. to care for animals after death. The results pave the way for clinical studies of this vaccine.
Scientists have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to new, effective therapies for people with some autoimmune and infectious diseases. Researchers have found that a natural metabolite called Itaconate can stimulate immune cells to make interferons by blocking an enzyme called SDH.